Source: International Congress 2016 – Scientific Year in Review 2016



Rating:

Share or cite this content

Citations should be made in the following way:
Bruno Crestani (Paris, France). Drug development: news from "hot" phase II trials. International Congress 2016 – Scientific Year in Review 2016

Member's Comments

No comment yet.

Related content which might interest you: Drug development: news from “hot” early stage clinical trials: personalised immunotherapy for lung cancer Source: International Congress 2017 – Scientific year in review Year: 2017 How do regulatory authorities feel about "PRO"? Source: Annual Congress 2012 - An ERS/ELF joint session "New tools to assess improvement in respiratory patients: capturing the patient's perspective" Year: 2012 Late Breaking Abstract - Masitinib in severe asthma: Results from a randomized, phase 3 trial Source: Virtual Congress 2020 – ALERT: Asthma in adults and children Year: 2020 Who to treat/who not to treat: the "non group I" PH patients Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020 Treatment of COPD and the TOnado trial: a tempest in a teapot? Source: Eur Respir J 2015; 45: 869-871 Year: 2015 Does "A" stand for alveolization? Source: Eur Respir J 2004; 23: 3-4 Year: 2004 What the scientific world is talking about in 2016: "The Lung Microbiome" Source: International Congress 2016 – Scientific Year in Review 2016 Year: 2016 Late Breaking Abstract - Efficacy and safety of tezepelumab in adults with severe asthma: A randomized phase 2 study Source: International Congress 2017 – Late-breaking studies in asthma and COPD Year: 2017 Can heat-non-burn tobacco be "non-burn" and "smokeless"? Source: International Congress 2018 – Systematic reviews on the health effects of emerging tobacco products and electronic nicotine delivery systems (ENDS) Year: 2018 Late Breaking Abstract - Long-term safety and efficacy of benralizumab in severe, uncontrolled asthma: first results of BORA, a randomized, Phase III extension study Source: International Congress 2018 – Notable Studies in Asthma Year: 2018 Efficacy of telespirometry made "on-line". Preliminary results Source: Eur Respir J 2006; 28: Suppl. 50, 201s Year: 2006 Late Breaking Abstract - Phase 1, first-in-human study of OATD-01, a dual chitinase inhibitor for the treatment of respiratory diseases Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018 Year in preview “acute" track Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Efficacy of CPAP and NIV in long term treatment of OHS: the results of the Spanish multicentre randomised trial "Pickwicks" Source: International Congress 2015 – Sleep-disordered breathing Year: 2015 Year in preview “chronic" track Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Alveolization: does "A" stand for appropriate morphometry? Source: Eur Respir J 2004; 24: 331-332 Year: 2004 Breathe is finally a real journal! Source: ISSN=ISSN 1810-6838, ISBN=, page=208 Year: 2006 Late Breaking Abstract - Target populations for type 2 asthma biologics in a real-life population in Spain (BRAVO 2) Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020